Gregory R Fulcher
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 22, 2024
Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study.Gregory R Fulcher, Neale D Cohen, Katherine Davies
|Oct 31, 2022
Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.Gregory R Fulcher, Shahid Akhtar, Saleh J Al-Jaser
|Jun 25, 2022
Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.Gregory R Fulcher, Shahid Akhtar, Saleh J Al-Jaser
|Dec 17, 2021
Correction: ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in realworld settings: rationale and design.Gregory R Fulcher, Henrik Jarlov, Johanne Spanggaard Piltoft
|Oct 12, 2021
ARISE-a prospective, non-interventional, single-arm study assessing clinical parameters associated with the use of insulin degludec/insulin aspart in patients with type 2 diabetes in real-world settings: rationale and design.Gregory R Fulcher, Henrik Jarlov, Johanne Spanggaard Piltoft
|Apr 07, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.Jie Yu, Jingwei Li, Phillip J Leaver
Pageof 1
